1-deoxynojirimycin has been researched along with Enlarged Spleen in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hughes, DA; Mehta, A; Thomas, AS | 1 |
| Bembi, B; Cox, TM; Deegan, P; Deroma, L; Hollak, C; Shemesh, E; Weinreb, NJ | 1 |
| Degtyareva, AV; Mikhailova, SV; Puchkova, AA; Tumanova, EL; Zakharova, EY | 1 |
| Chérin, P; Giraldo, P; Mehta, A; Pastores, GM | 1 |
| Sedel, F | 1 |
| Lo, SM; McNamara, J; Mistry, PK; Seashore, MR | 1 |
| Czartoryska, B; Groener, JE; Jurkiewicz, E; Kamiński, ML; Tylki-Szymańska, A; Ługowska, A | 1 |
| McKiernan, P | 1 |
| Klünemann, HH; Santosh, PJ; Sedel, F | 1 |
| Stirnemann, J | 1 |
| Germain, DP; Mistry, P | 1 |
| Chippington, S; McHugh, K; Vellodi, A | 1 |
| Mistry, PK | 1 |
5 review(s) available for 1-deoxynojirimycin and Enlarged Spleen
| Article | Year |
|---|---|
Gaucher disease: haematological presentations and complications.
Topics: 1-Deoxynojirimycin; Anemia; Combined Modality Therapy; Disease Management; Enzyme Replacement Therapy; Gaucher Disease; Genetic Predisposition to Disease; Glucosylceramidase; Glycosphingolipids; Hemorrhagic Disorders; Humans; Inflammation; Lewy Body Disease; Lysosomes; Macrophage Activation; Multiple Myeloma; Parkinson Disease; Splenectomy; Splenomegaly; Thrombocytopenia; Unfolded Protein Response | 2014 |
Enzyme replacement and substrate reduction therapy for Gaucher disease.
Topics: 1-Deoxynojirimycin; Enzyme Inhibitors; Enzyme Replacement Therapy; Gaucher Disease; Glucosylceramidase; Hemoglobin A; Hepatomegaly; Humans; Platelet Count; Randomized Controlled Trials as Topic; Splenomegaly; Substrate Specificity | 2015 |
Goal-oriented therapy with miglustat in Gaucher disease.
Topics: 1-Deoxynojirimycin; Adult; Aged; Bone and Bones; Female; Gaucher Disease; Hepatomegaly; Humans; Lung; Male; Middle Aged; Splenomegaly | 2009 |
[Clinical diagnosis of the adult form of Niemann-Pick type C disease].
Topics: 1-Deoxynojirimycin; Adult; Cerebellar Ataxia; Cognition Disorders; Deglutition Disorders; Dysarthria; Enzyme Inhibitors; Epilepsy; Humans; Mental Disorders; Movement Disorders; Niemann-Pick Disease, Type C; Splenomegaly; Supranuclear Palsy, Progressive | 2010 |
Treatable metabolic psychoses that go undetected: what Niemann-Pick type C can teach us.
Topics: 1-Deoxynojirimycin; Age of Onset; Ataxia; Diagnosis, Differential; Disease Progression; Enzyme Inhibitors; Genetic Testing; Humans; Magnetic Resonance Spectroscopy; Niemann-Pick Disease, Type C; Ophthalmoplegia; Prevalence; Psychotic Disorders; Splenomegaly; Treatment Outcome | 2012 |
1 trial(s) available for 1-deoxynojirimycin and Enlarged Spleen
| Article | Year |
|---|---|
[Clinical study of the French cohort of Gaucher disease patients].
Topics: 1-Deoxynojirimycin; Adolescent; Adult; Aged; Aged, 80 and over; Asthenia; Biomarkers; Child; Child, Preschool; Cohort Studies; Enzyme Inhibitors; Follow-Up Studies; Forecasting; France; Gaucher Disease; Glucosylceramidase; Humans; Infant; Infant, Newborn; Middle Aged; Recombinant Proteins; Splenectomy; Splenomegaly; Time Factors; Treatment Outcome | 2006 |
7 other study(ies) available for 1-deoxynojirimycin and Enlarged Spleen
| Article | Year |
|---|---|
Visceral symptoms as a key diagnostic sign for the early infantile form of Niemann-Pick disease type C in a Russian patient: a case report.
Topics: 1-Deoxynojirimycin; Child, Preschool; Cholestasis, Intrahepatic; Diagnostic Errors; Galactosemias; Genetic Testing; Glycoside Hydrolase Inhibitors; Hepatomegaly; Humans; Infant; Infant, Newborn; Jaundice, Neonatal; Liver; Male; Niemann-Pick Disease, Type C; Russia; Splenomegaly | 2016 |
Misdiagnosis of Niemann-Pick disease type C as Gaucher disease.
Topics: 1-Deoxynojirimycin; Acid Phosphatase; Biomarkers; Carrier Proteins; Cells, Cultured; Cholesterol Esters; Diagnostic Errors; DNA Mutational Analysis; Enzyme Inhibitors; Enzyme Replacement Therapy; Esterification; Female; Gaucher Disease; Genetic Predisposition to Disease; Glucosylceramidase; Glucosyltransferases; Hepatomegaly; Heterozygote; Hexosaminidases; Humans; Infant; Intracellular Signaling Peptides and Proteins; Isoenzymes; Membrane Glycoproteins; Mutation; Niemann-Pick C1 Protein; Niemann-Pick Disease, Type C; Phenotype; Predictive Value of Tests; Splenomegaly; Tartrate-Resistant Acid Phosphatase; Unnecessary Procedures | 2010 |
Gaucher disease due to saposin C deficiency, previously described as non-neuronopathic form--no positive effects after 2-years of miglustat therapy.
Topics: 1-Deoxynojirimycin; Adult; Diagnostic Errors; Enzyme Inhibitors; Female; Gaucher Disease; Hepatomegaly; Humans; Male; Saposins; Splenomegaly; Treatment Failure | 2011 |
Metabolic liver disease.
Topics: 1-Deoxynojirimycin; Cyclohexanones; Diet; Enzyme Inhibitors; Enzyme Replacement Therapy; Hepatocytes; Hepatomegaly; Humans; Hydrops Fetalis; Infant; Infant, Newborn; Jaundice, Neonatal; Liver Diseases; Liver Transplantation; Metabolism, Inborn Errors; Nitrobenzoates; Splenomegaly | 2012 |
Therapeutic goals in Gaucher disease.
Topics: 1-Deoxynojirimycin; Adolescent; Adult; Age Factors; Child; Evidence-Based Medicine; Gaucher Disease; Glucosylceramidase; Glycoside Hydrolase Inhibitors; Humans; Injections, Intravenous; Phenotype; Quality of Life; Recombinant Proteins; Splenectomy; Splenomegaly; Time Factors | 2006 |
Splenic nodules in paediatric Gaucher disease treated by enzyme replacement therapy.
Topics: 1-Deoxynojirimycin; Child; Child, Preschool; Cohort Studies; Enzyme Inhibitors; Female; Follow-Up Studies; Gaucher Disease; Glucosylceramidase; Humans; Infant; Male; Retrospective Studies; Spleen; Splenic Diseases; Splenomegaly; Ultrasonography | 2008 |
Treatment of Gaucher's disease with OGT 918.
Topics: 1-Deoxynojirimycin; Enzyme Inhibitors; Gaucher Disease; Glucosylceramidase; Glucosylceramides; Glycoside Hydrolase Inhibitors; Hepatomegaly; Hexosaminidases; Humans; Splenomegaly; Time | 2000 |